Control of IgE responses: II. Isotype specific suppression of peak hapten specific IgE antibody forming cell responses in BPO-KLH sensitized mice after oral administration of muramyldipeptide or murabutide
- 31 October 1993
- journal article
- research article
- Published by Elsevier in Immunopharmacology
- Vol. 26 (2) , 157-169
- https://doi.org/10.1016/0162-3109(93)90008-e
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factorPublished by Elsevier ,2004
- Influence of a muramyl dipeptide on human blood leukocyte functions and their membrane antigensCellular Immunology, 1991
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells.The Journal of Experimental Medicine, 1990
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- IgE-Binding Factors and Regulation of the IgE Antibody ResponseAnnual Review of Immunology, 1988
- Modulation of ongoing human immunoglobulin synthesis by natural killer cellsCellular Immunology, 1987
- Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype ProductionScience, 1987
- IgE Fc Receptor Positive T, B and NK Cells in Patients with the Hyper-IgE SyndromeInternational Archives of Allergy and Immunology, 1985
- Origin and fate of IgE-bearing lymphocytes. I. Peyer's patches as differentiation site of cells. Simultaneously bearing IgA and IgE.The Journal of Experimental Medicine, 1981